Compare MHH & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MHH | STRO |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.7M | 85.0M |
| IPO Year | 2008 | N/A |
| Metric | MHH | STRO |
|---|---|---|
| Price | $6.58 | $25.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $18.88 |
| AVG Volume (30 Days) | 16.3K | ★ 139.7K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $198,943,000.00 | N/A |
| Revenue This Year | $2.93 | $63.08 |
| Revenue Next Year | $8.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.51 | $0.52 |
| 52 Week High | $10.91 | $25.68 |
| Indicator | MHH | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 53.64 | 79.52 |
| Support Level | $6.64 | $0.76 |
| Resistance Level | $7.92 | N/A |
| Average True Range (ATR) | 0.37 | 1.96 |
| MACD | 0.07 | 0.50 |
| Stochastic Oscillator | 77.02 | 97.92 |
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.